4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-042032
Options or other derivatives
- Chief Business Officer acquired 35,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| McNeill Jonathan Chief Business Officer | 2023-07-11 | Grant or award · Stock option (right to buy) | +35,000 | 35,000 | D | ||
Loading xslF345X05/ownership.xml…